What data does the API provide for GILD?

Company profile, financial statements, computed ratios, price data, filings and news for GILD, via REST endpoints under /api/v1/companies/GILD. Every financial field carries a source tag for provenance.

How complete is GILD's financial data?

The anchor reporting period (FY2025) has 100.0% of the 17 core statement fields populated. Primary source: sec_edgar.

What reporting periods are covered for GILD?

5 fiscal-year periods are stored (FY2021–FY2025), with per-period field counts and source tags available via /api/v1/companies/GILD/financials.

Where does GILD's data come from?

Primary source for the latest statements: sec_edgar. The API records a source tag on every field and exposes them via /api/v1/companies/GILD/financials, so each value is traceable.

GILD — Gilead Sciences API Data: Financials, Filings, Coverage

Profile

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy for the treatment of adult patients; Trodelvy, an injection for intravenous use; and Yescarta, a suspension for intravenous infusion, is a CAR T-cell therapy for the treatment of adult patients. Further, it provides AmBisome, for the treatment of serious invasive fungal infections; and Veklury for the treatment of COVID-19. Additionally, the company engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company has collaboration agreements with Shenzhen Pregene Biopharma Co., Ltd.; Abingworth; Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Employees: 17,000 · Website: https://www.gilead.com · Profile fields populated: 75%

Data completeness by statement

Share of stored fields populated in the anchor reporting period (FY2025), primary source sec_edgar. Full per-field breakdown: GET /api/v1/companies/GILD/financials.

Income statement9/10 fields (90.0%)

Balance sheet14/14 fields (100.0%)

Cash flow6/6 fields (100.0%)

Per-share3/4 fields (75.0%)

Financial statement coverage (USD)

Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.

Period	Period end	Fields populated	Source
FY2025	2025-12-31	29	sec_edgar
FY2024	2024-12-31	29	sec_edgar
FY2023	2023-12-31	29	sec_edgar
FY2022	2022-12-31	29	sec_edgar
FY2021	2021-12-31	29	sec_edgar

Get GILD data via the API

Every number on this page is one API call away. Free API keys — no card required.

Company profile

Name, sector, industry, HQ, employees, market cap, source-tagged.

GET /api/v1/companies/GILD

Financial statements

Multi-year statements with per-field source tags and completeness.

GET /api/v1/companies/GILD/financials

Computed ratios

P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.

GET /api/v1/companies/GILD/metrics/summary

Filings archive

Report PDFs with LLM-ready markdown conversions where available.

GET /api/v1/companies/GILD/filings

News & announcements

Dated press releases and announcements with source links.

GET /api/v1/companies/GILD/news

Quick start

Create a free key, then:

curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/GILD

Query GILD programmatically

Free tier — instant API key. Built for AI agents.

API Docs AI Agent Setup

Other NASDAQ · Health Care companies covered

Vertex Pharmaceuticals

MRNA

Moderna

REGN

Regeneron Pharmaceuticals

Frequently Asked Questions

What data does the API provide for GILD?: Company profile, financial statements, computed ratios, price data, filings and news for GILD, via REST endpoints under /api/v1/companies/GILD. Every financial field carries a source tag for provenance.
How complete is GILD's financial data?: The anchor reporting period (FY2025) has 100.0% of the 17 core statement fields populated. Primary source: sec_edgar.
What reporting periods are covered for GILD?: 5 fiscal-year periods are stored (FY2021–FY2025), with per-period field counts and source tags available via /api/v1/companies/GILD/financials.
Where does GILD's data come from?: Primary source for the latest statements: sec_edgar. The API records a source tag on every field and exposes them via /api/v1/companies/GILD/financials, so each value is traceable.